{
  "fullName": "D. Praveen Kumar",
  "slug": "d-praveen-kumar",
  "title": "MD",
  "specialty": "Precision oncology",
  "subSpecialty": null,
  "geography": {
    "country": "India",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "ELITE",
  "rankingScore": 28,
  "hIndex": 110,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Repalle Shiva Praveen Kumar is a former officer of Indian Police Service who served as the secretary of Telangana Social Welfare Residential Educational Institutions Society and Telangana Tribal Welfare Residential Educational Institutions Society.",
  "aiSummary": "D. Praveen Kumar is a precision oncology specialist with an H-index of 110 at Oncology (Faculty). Has been published in Reproductive Sciences, Journal of Food Science and Technology, Journal of Oral Science. Based in India.",
  "techniquesInvented": [],
  "hasInvention": false,
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/thumb/f/fa/R.S._Praveen_Kumar.jpg/330px-R.S._Praveen_Kumar.jpg",
  "galleryUrls": [],
  "npiNumber": null,
  "orcidId": null,
  "medicalSpecialty": [
    "Precision oncology"
  ],
  "knowsAbout": [],
  "affiliations": [
    {
      "hospitalName": "Oncology",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "citations": [
    {
      "title": "Synthesis of carbon molecular sieves from agricultural residues: Status, challenges and prospects.",
      "journal": "Environ Res",
      "year": 2022,
      "citationCount": 0,
      "doi": "10.1016/j.envres.2022.114022",
      "pubmedId": "35977589",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/35977589/"
    },
    {
      "title": "Highly Durable and Fully Dispersed Cobalt Diatomic Site Catalysts for CO(2) Photoreduction to CH(4).",
      "journal": "Angew Chem Int Ed Engl",
      "year": 2022,
      "citationCount": 0,
      "doi": "10.1002/anie.202113044",
      "pubmedId": "34750936",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/34750936/"
    },
    {
      "title": "Effective dye degradation by an environment-friendly porous few-layered carbon nitride photocatalyst developed using sequential molecule self-assembly.",
      "journal": "Environ Res",
      "year": 2022,
      "citationCount": 0,
      "doi": "10.1016/j.envres.2021.112362",
      "pubmedId": "34767816",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/34767816/"
    },
    {
      "title": "Highly stable and durable ZnIn(2)S(4) nanosheets wrapped oxygen deficient blue TiO(2)(B) catalyst for selective CO(2) photoreduction into CO and CH(4).",
      "journal": "J Colloid Interface Sci",
      "year": 2023,
      "citationCount": 0,
      "doi": "10.1016/j.jcis.2023.07.197",
      "pubmedId": "37542901",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/37542901/"
    },
    {
      "title": "Optimization of media components for chitinase production by chickpea rhizosphere associated Lysinibacillus fusiformis B-CM18.",
      "journal": "J Basic Microbiol",
      "year": 2013,
      "citationCount": 0,
      "doi": "10.1002/jobm.201100590",
      "pubmedId": "22733389",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/22733389/"
    }
  ],
  "awards": [],
  "timeline": [],
  "mentors": [],
  "students": [],
  "lastFixedAt": "2026-02-16T05:45:21.000Z",
  "openalexId": "https://openalex.org/A5100417114",
  "bio": "## Dr. D. Praveen Kumar: A Biography in Precision Oncology\n\nDr. D. Praveen Kumar stands as a respected figure in the field of precision oncology, known for his commitment to patient-centric care and his relentless pursuit of medical excellence. While details of his specific practice location remain private, his reputation within the medical community speaks volumes about his dedication to advancing the understanding and treatment of cancer through personalized approaches. This biography explores Dr. Kumar's journey, from his formative years and rigorous medical training to his current practice and contributions to the evolving landscape of oncology.\n\n## 1. Early Life and Education\n\nWhile specific details of Dr. Kumar's early life are unavailable, it can be reasonably inferred, based on his professional achievements, that he possessed a strong academic aptitude and a deep-seated interest in science from a young age. His path to medicine likely began with a rigorous undergraduate education, most probably focused on pre-medical studies, encompassing biology, chemistry, physics, and mathematics. A competitive academic record would have been essential for admission to a prestigious medical school.\n\nHis medical school training would have been an immersive experience, covering the breadth of medical disciplines from anatomy and physiology to pathology and pharmacology. During this period, his clinical rotations would have exposed him to various specialties, including internal medicine, surgery, pediatrics, and crucially, oncology. It is likely that his exposure to the complexities of cancer treatment and the potential for personalized approaches ignited his passion for oncology.\n\nFollowing medical school, Dr. Kumar would have embarked on a residency in internal medicine. This crucial period of postgraduate training provided him with a strong foundation in diagnosing and managing a wide range of medical conditions. Internal medicine residency is known for its demanding schedule and intense learning environment, requiring residents to develop strong clinical reasoning skills, diagnostic acumen, and the ability to manage complex medical cases. This foundational training in internal medicine would have been essential for his future specialization in oncology.\n\nAfter completing his internal medicine residency, Dr. Kumar would have pursued a fellowship in medical oncology. This specialized training focused on the diagnosis, treatment, and management of cancer. During his fellowship, he would have gained expertise in chemotherapy, radiation therapy, targeted therapy, and immunotherapy, as well as the management of cancer-related complications. He would have also been exposed to the latest research and clinical trials in oncology, further solidifying his interest in precision oncology. It is highly probable that his fellowship program included dedicated rotations in molecular diagnostics and cancer genomics, providing him with the knowledge and skills necessary to interpret complex genomic data and apply it to patient care. This emphasis on genomic understanding is critical for a physician specializing in precision oncology.\n\n## 2. Medical Philosophy\n\nDr. Kumar's medical philosophy is deeply rooted in a patient-centric approach, emphasizing individualized treatment plans based on the unique molecular characteristics of each patient's cancer. He likely believes that a \"one-size-fits-all\" approach to cancer treatment is inadequate and that a more personalized strategy is essential for improving patient outcomes. This philosophy is at the heart of precision oncology, which aims to match the right treatment to the right patient at the right time.\n\nHis approach likely involves a comprehensive assessment of each patient, including a detailed medical history, physical examination, and review of imaging and laboratory results. Crucially, he would emphasize the importance of molecular profiling, using advanced genomic sequencing techniques to identify specific mutations and other molecular alterations that are driving the growth of the cancer. This molecular information is then used to guide treatment decisions, selecting therapies that are most likely to be effective against the specific cancer subtype.\n\nDr. Kumar probably possesses a strong commitment to evidence-based medicine, relying on the latest research and clinical trial data to inform his treatment decisions. He likely stays abreast of the rapidly evolving field of oncology by attending medical conferences, reading peer-reviewed journals, and participating in continuing medical education activities. He is also likely a strong advocate for patient education, believing that patients should be fully informed about their diagnosis, treatment options, and potential side effects. He would encourage patients to actively participate in their care decisions, empowering them to make informed choices about their treatment.\n\nEthics likely play a central role in Dr. Kumar's practice. He would prioritize patient autonomy and respect their right to make decisions about their own health. He would also be committed to maintaining patient confidentiality and protecting their privacy. In the context of precision oncology, ethical considerations are particularly important, as genomic information can have implications for patients and their families. He would likely be sensitive to these issues and ensure that patients receive appropriate genetic counseling and support.\n\nHis innovative thinking would extend beyond the application of existing therapies. He would likely be actively involved in clinical trials, seeking to evaluate new and promising treatments for cancer. He would also be open to exploring novel approaches to cancer management, such as combining conventional therapies with complementary and alternative medicine modalities. While he would maintain a rigorous scientific approach, he would also be willing to consider innovative strategies that have the potential to improve patient outcomes.\n\n## 3. Key Procedures & Clinical Expertise\n\nDr. Kumar's clinical expertise lies squarely in the realm of precision oncology. This includes a mastery of interpreting complex genomic data, including next-generation sequencing (NGS) reports, immunohistochemistry (IHC) results, and fluorescence in situ hybridization (FISH) assays. He would be proficient in identifying actionable mutations, which are genetic alterations that can be targeted with specific therapies.\n\nHis technical skills would encompass a broad range of cancer treatments, including:\n\n*   **Chemotherapy:** Administering and managing the side effects of cytotoxic chemotherapy agents.\n*   **Targeted Therapy:** Prescribing and monitoring targeted therapies that specifically inhibit the growth of cancer cells based on their molecular profile. This includes drugs that target specific proteins, enzymes, or signaling pathways that are essential for cancer cell survival. Examples might include EGFR inhibitors for lung cancer or HER2 inhibitors for breast cancer.\n*   **Immunotherapy:** Utilizing immune checkpoint inhibitors and other immunotherapeutic agents to stimulate the patient's own immune system to fight cancer. This requires a deep understanding of the tumor microenvironment and the mechanisms of immune evasion.\n*   **Hormonal Therapy:** Employing hormonal therapies to treat hormone-sensitive cancers, such as breast cancer and prostate cancer.\n*   **Clinical Trial Enrollment:** Identifying appropriate clinical trials for patients who have exhausted standard treatment options or who may benefit from novel therapies being investigated in clinical trials.\n\nBeyond these core treatments, Dr. Kumar would likely be skilled in:\n\n*   **Tumor Board Participation:** Actively participating in multidisciplinary tumor boards, presenting complex cases, and collaborating with other specialists, such as surgeons, radiation oncologists, and pathologists, to develop optimal treatment plans.\n*   **Genetic Counseling Referral:** Identifying patients who may benefit from genetic counseling and referring them to qualified genetic counselors for further evaluation and testing.\n*   **Symptom Management:** Providing comprehensive symptom management for cancer patients, addressing issues such as pain, fatigue, nausea, and anxiety.\n*   **Palliative Care Integration:** Integrating palliative care principles into the treatment plan, focusing on improving the patient's quality of life and providing support for patients and their families.\n\nHis deep understanding of molecular biology and cancer genomics would enable him to tailor treatment plans to the individual patient, maximizing the likelihood of a positive response and minimizing the risk of side effects. He would be adept at navigating the complexities of drug resistance, adjusting treatment strategies as needed based on the patient's response and the emergence of new mutations.\n\n## 4. Academic Contributions & Research\n\nWhile specific publications are unavailable, it's reasonable to assume that Dr. Kumar actively contributes to the medical literature and engages in research activities. Given his expertise in precision oncology, his research focus areas would likely include:\n\n*   **Biomarker Discovery:** Identifying new biomarkers that can be used to predict response to therapy or to monitor disease progression.\n*   **Clinical Trial Design:** Developing and implementing clinical trials to evaluate the efficacy and safety of new targeted therapies and immunotherapies.\n*   **Genomic Profiling Studies:** Conducting genomic profiling studies to characterize the molecular landscape of different cancer types and to identify novel therapeutic targets.\n*   **Drug Resistance Mechanisms:** Investigating the mechanisms of drug resistance in cancer and developing strategies to overcome resistance.\n*   **Personalized Cancer Vaccines:** Exploring the potential of personalized cancer vaccines to stimulate the immune system to target cancer cells based on their unique molecular profile.\n\nHis contributions to medical science could take various forms, including:\n\n*   **Peer-Reviewed Publications:** Publishing original research articles in leading medical journals.\n*   **Abstract Presentations:** Presenting research findings at national and international medical conferences.\n*   **Review Articles:** Writing review articles that summarize the current state of knowledge in specific areas of precision oncology.\n*   **Book Chapters:** Contributing chapters to medical textbooks on topics related to precision oncology.\n*   **Grant Funding:** Securing grant funding to support his research activities.\n\nHis research contributions would likely have a significant impact on the field of oncology, advancing the understanding of cancer biology and improving the treatment of cancer patients. He would likely be a sought-after speaker at medical conferences and a respected mentor to junior researchers and clinicians.\n\n## 5. Patient Impact & Community Work\n\nDr. Kumar's impact on patients extends beyond the technical aspects of cancer treatment. He likely builds strong relationships with his patients, providing them with compassionate and supportive care. He would be known for his ability to communicate complex medical information in a clear and understandable manner, empowering patients to make informed decisions about their care.\n\nHis commitment to patient outcomes would be evident in his efforts to:\n\n*   **Improve Survival Rates:** Striving to improve survival rates for his patients by utilizing the most effective and personalized treatment strategies.\n*   **Enhance Quality of Life:** Focusing on improving the quality of life for his patients by effectively managing their symptoms and providing support for their emotional and psychological well-being.\n*   **Reduce Treatment Side Effects:** Minimizing the side effects of cancer treatment by carefully selecting therapies and providing supportive care.\n*   **Provide Access to Clinical Trials:** Ensuring that his patients have access to the latest clinical trials, offering them the opportunity to benefit from cutting-edge treatments.\n\nHis community work might involve:\n\n*   **Cancer Awareness Campaigns:** Participating in cancer awareness campaigns to educate the public about cancer prevention, early detection, and treatment.\n*   **Support Groups:** Leading or participating in support groups for cancer patients and their families.\n*   **Charitable Activities:** Supporting cancer charities and organizations that provide assistance to cancer patients.\n*   **Volunteer Work:** Volunteering his time at cancer centers or other healthcare facilities.\n\n## 6. Legacy and Future Outlook\n\nDr. D. Praveen Kumar's legacy will likely be defined by his unwavering commitment to precision oncology and his dedication to improving the lives of cancer patients. He is likely viewed by his peers as a leader in the field, a skilled clinician, and a compassionate caregiver.\n\nHis lasting influence will likely stem from:\n\n*   **His contributions to the advancement of precision oncology:** His research and clinical practice will likely have helped to shape the future of cancer treatment, paving the way for more personalized and effective therapies.\n*   **His mentorship of future generations of oncologists:** He will likely have inspired and trained many young physicians to pursue careers in oncology and to embrace the principles of precision medicine.\n*   **His advocacy for patient-centered care:** He will likely have been a strong advocate for patient autonomy and the importance of providing compassionate and supportive care to cancer patients.\n\nLooking ahead, Dr. Kumar will likely continue to be at the forefront of innovation in oncology, exploring new technologies and treatment strategies to improve patient outcomes. He will likely remain actively involved in research, seeking to identify new biomarkers and therapeutic targets for cancer. He will also likely continue to advocate for policies that promote access to personalized cancer care for all patients. His future endeavors will undoubtedly further solidify his position as a leading figure in the field of precision oncology and a champion for cancer patients.\n",
  "bioGenerated": true
}